- Home
- FMBH vs ORIC Comparison
FMBH vs ORIC Comparison
Compare FMBH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMBH | ORIC |
|---|---|---|
| Founded | 1865 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FMBH | ORIC |
|---|---|---|
| Price | $50.52 | $13.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 16 |
| Target Price | ★ $56.36 | $21.64 |
| AVG Volume (30 Days) | 127.2K | ★ 1.4M |
| Earning Date | 11-02-2026 | 11-12-2026 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | 16.06 | ★ 19.67 |
| EPS | ★ 2.10 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.02 | N/A |
| Revenue Next Year | $6.22 | N/A |
| P/E Ratio | $23.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.51 | $7.23 |
| 52 Week High | $53.36 | $14.68 |
Technical Indicators
Market Signals| Indicator | FMBH | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 57.04 | 59.43 |
| Support Level | $50.49 | $13.12 |
| Resistance Level | $51.58 | $14.22 |
| Average True Range (ATR) | 1.01 | 0.83 |
| MACD | 0.16 | 0.20 |
| Stochastic Oscillator | 92.97 | 79.32 |
Price Performance
Historical ComparisonAbout FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.